CAM acts as counsel to EAAA India Alternatives Ltd. and Avendus Finance Pvt. Ltd. in connection with a secured financing of INR 585 crores raised by Gujarat Themis Biosyn Ltd.
The proceeds of the financing were primarily used by the Issuer to fund part of the consideration for its acquisition of Micro Biopharm Japan Company Limited in Japan.
